CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Axim Biotechnologies, Inc.  (AXIM)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

Axim Biotechnologies Income Statement Quarterly

AXIM


INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Total Revenue 0.019 0.012 0.010 0.011 0.014
   Cost of Goods Sold 0.039 0.113 0.014 0.012 0.015
Gross Profit -0.020 -0.101 -0.004 -0.001 -0.001
   Selling, Administration, Marketing 0.315 0.597 1.463 0.445 0.909
   Depriciation & Amortization 0.026 0.024 0.004 0.001 0.001
   Research and Development Expense 0.140 0.072 0.088 0.045 0.031
   Restructuring, Accretion & impairment charges - - - - -
   Other operatinig exp. /-income -0.025 -0.023 -0.003 - 0.000
   Unusual Expense /-Income - - - - -
 Total operating costs including COS 0.495 0.782 1.565 0.503 0.956
Operating income/-loss -0.476 -0.770 -1.556 -0.491 -0.942
Other Deductions / - Income
   Interest expense 0.025 0.026 0.225 0.012 0.012
   Interest income - - - - -
   Net interest expense/-income 0.025 0.026 0.225 0.012 0.012
   Extinguishment of Debt - - - 1.385 -
   Investment Income, Interest -0.002 - - - -
   Foreign Currency Transaction (Gain) Loss - - - - -
   Allowances, Health Care Trust Fund And Other - - - - -
   Unexpected (Gain) Loss - - - - -
   Other loss/ -income 0.025 0.023 0.003 -0.000 -0.000
   Loss On Change In Fair Value Of Derivative Liability - -0.212 - - -
   Loss On Settlement Of Liability - -0.152 - - -
 Total costs & expenses 0.543 1.196 1.793 1.900 0.968
Income /-loss before income taxes -0.524 -1.184 -1.784 -1.889 -0.954
   Income taxes expenses/-benefit - - - - -
Income after income taxes -0.524 -1.184 -0.309 -1.889 -0.954
   Net income/-loss of other equity - - 1.475 - -
Income/-loss from cont. Ops. -0.524 -1.184 -0.309 -1.889 -0.954
   Accounting change - - - - -
   Discontinued operations - - - - -
   Extraordinary items - - - - -
Net Income/-loss -0.524 -1.184 -0.309 -1.889 -0.954
   Noncontrolling interests - - - - -
   Prefered dividends - - -1.475 - -
   Other - - - - -
Income/-loss to shareholder -0.524 -1.184 -1.784 -1.889 -0.954
   EBIT -0.500 -1.157 -1.558 -1.876 -0.942
   EBITD -0.499 -1.156 -1.557 -1.876 -0.941
   EBITDA -0.499 -1.156 -1.557 -1.876 -0.941

Per Share (GAAP Quarterly, in $) (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Basic EPS (excl. extra items) -0.01 -0.03 -0.07 -0.05 -0.02
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -0.01 -0.03 -0.07 -0.05 -0.02
Basic shares outstanding (Mill. of Units) 52.516 43.127 44.330 39.763 39.710
   EPS other shares - - - - -
Diluted Net EPS -0.01 -0.03 -0.07 -0.05 -0.02
Diluted average shares (Mill. of Units) 52.516 43.127 44.330 39.763 39.710
Dividend per share - - - - -


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com